Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1253 USD | +1.05% | +13.29% | -16.47% |
Apr. 19 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Bioxytran, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 21.85M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net Debt 2022 | 1.87M | Net Debt 2023 | 1.9M | EV / Sales 2023 | - |
P/E ratio 2022 |
-22.4
x | P/E ratio 2023 |
-4.7
x | Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.12% |
1 day | -3.88% | ||
1 week | +12.73% | ||
Current month | +11.61% | ||
1 month | +5.98% | ||
3 months | +0.98% | ||
6 months | -14.54% | ||
Current year | -17.33% |
Managers | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 18-02-28 |
Ola Soderquist
DFI | Director of Finance/CFO | 63 | - |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 18-02-28 |
Dale Conaway
BRD | Director/Board Member | 69 | 18-11-01 |
Anders Utter
BRD | Director/Board Member | 57 | 18-11-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.1253 | +1.05% | 8 454 |
24-05-16 | 0.124 | -3.88% | 10,734 |
24-05-15 | 0.129 | +2.58% | 178,681 |
24-05-14 | 0.1258 | +9.35% | 152,000 |
24-05-13 | 0.115 | +3.98% | 174,409 |
Delayed Quote OTC Markets, May 16, 2024 at 03:54 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-17.33% | 21.7M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.55% | 22.28B | |
-11.90% | 22.41B | |
-5.24% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- BIXT Stock